Ismail CEYLAN

Ismail CEYLAN serves as the Président and CEO of Advanced Biodesign since August 2010, where the company has pioneered a novel therapeutic strategy targeting cancer by inhibiting the intracellular detoxification mechanisms utilized by cancerous cells to evade apoptosis. Prior to this role, Ismail CEYLAN was the Technical Director and Research Engineer at Covalab from 2000 to 2010, contributing to innovations in the field.